Related Experiment Video
Updated: Jul 6, 2026

11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular
Terri L McKay1, Dan J Gedeon, Mary B Vickerman
1Research & Technology Directorate and National Center for Space Exploration Research, NASA Glenn Research Center, Cleveland, Ohio 44135, USA.
Investigative Ophthalmology & Visual Science
|March 11, 2008
Summary
Triamcinolone acetonide (TA) inhibits smaller blood vessel growth and reduces diameter in all vessels. This steroid impacts angiogenesis by affecting vessel density and branching in quail embryos.
Area of Science:
- Developmental biology
- Angiogenesis research
- Pharmacology
Background:
- The chorioallantoic membrane (CAM) of quail embryos is a widely used model for studying angiogenesis.
- Steroids are known to influence vascular development, but their specific effects on microvascular branching are not fully understood.
Purpose of the Study:
- To quantify the effects of triamcinolone acetonide (TA) on the branching morphology of the angiogenic microvascular tree in quail embryo CAM.
- To investigate how TA influences key vascular parameters like vessel diameter, fractal dimension, and vessel densities.
Main Methods:
- Quail embryos at embryonic day 7 were treated with varying concentrations of TA (0-16 ng/mL) applied topically to the CAM.
- Microscopic images of arterial end points were analyzed using VESGEN software for generational analysis of vessel branching.
- Vascular parameters including vessel diameter (D(v)), fractal dimension (D(f)), and densities (A(v), L(v), N(v), Br(v)) were quantified.
Main Results:
- Increasing TA concentrations significantly decreased vessel density (up to 34%) across parameters A(v), L(v), Br(v), N(v), and D(f).
- TA selectively inhibited the growth of smaller vessels (generations G(7)-G(10)), reducing length (L(v)) and number (N(v)).
- Vessel diameter (D(v)) was reduced throughout all vascular generations (G(1)-G(10)).
Conclusions:
- Triamcinolone acetonide selectively inhibits angiogenesis of smaller blood vessels within the CAM.
- TA also decreases the vessel diameter of all vessels, indicating a broad impact on vascular morphology.
- The VESGEN analysis provides a quantitative method to assess steroid-induced changes in vascular development.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
